Aperio Group’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $398K | Sell |
100,821
-4,319
| -4% | -$18K | ﹤0.01% | 2066 |
|
|
2020
Q3 | $388K | Sell |
105,140
-3,099
| -3% | -$13.1K | ﹤0.01% | 1956 |
|
|
2020
Q2 | $369K | Sell |
108,239
-26,580
| -20% | -$59.5K | ﹤0.01% | 1925 |
|
|
2020
Q1 | $180K | Buy |
134,819
+67,446
| +100% | +$106K | ﹤0.01% | 2117 |
|
|
2019
Q4 | $99K | Sell |
67,373
-15,889
| -19% | -$26.6K | ﹤0.01% | 2263 |
|
|
2019
Q3 | $174K | Buy |
83,262
+10,473
| +14% | +$21.4K | ﹤0.01% | 2187 |
|
|
2019
Q2 | $177K | Buy |
72,789
+12,631
| +21% | +$27.6K | ﹤0.01% | 2221 |
|
|
2019
Q1 | $157K | Sell |
60,158
-27,045
| -31% | -$81.9K | ﹤0.01% | 2198 |
|
|
2018
Q4 | $263K | Buy |
87,203
+12,345
| +16% | +$41.9K | ﹤0.01% | 2004 |
|
|
2018
Q3 | $259K | Sell |
74,858
-9,097
| -11% | -$48.3K | ﹤0.01% | 2085 |
|
|
2018
Q2 | $394K | Buy |
83,955
+35,168
| +72% | +$133K | ﹤0.01% | 1864 |
|
|
2018
Q1 | $155K | Buy |
48,787
+1,967
| +4% | +$7.92K | ﹤0.01% | 2177 |
|
|
2017
Q4 | $229K | Buy |
46,820
+1,388
| +3% | +$8.05K | ﹤0.01% | 2088 |
|
|
2017
Q3 | $312K | Sell |
45,432
-3,324
| -7% | -$21K | ﹤0.01% | 1900 |
|
|
2017
Q2 | $320K | Sell |
48,756
-13,776
| -22% | -$96.6K | ﹤0.01% | 1864 |
|
|
2017
Q1 | $500K | Buy |
62,532
+3,613
| +6% | +$30.4K | ﹤0.01% | 1545 |
|
|
2016
Q4 | $548K | Sell |
58,919
-958
| -2% | -$9.91K | ﹤0.01% | 1456 |
|
|
2016
Q3 | $634K | Buy |
59,877
+2,629
| +5% | +$26.2K | ﹤0.01% | 1319 |
|
|
2016
Q2 | $535K | Sell |
57,248
-5,794
| -9% | -$58.8K | ﹤0.01% | 1350 |
|
|
2016
Q1 | $655K | Buy |
63,042
+25,312
| +67% | +$231K | 0.01% | 1239 |
|
|
2015
Q4 | $379K | Sell |
37,730
-31,424
| -45% | -$315K | ﹤0.01% | 1493 |
|
|
2015
Q3 | $582K | Buy |
69,154
+46,204
| +201% | +$612K | 0.01% | 1216 |
|
|
2015
Q2 | $369K | Buy |
22,950
+6,247
| +37% | +$97.2K | ﹤0.01% | 1497 |
|
|
2015
Q1 | $237K | Sell |
16,703
-2,433
| -13% | -$31.7K | ﹤0.01% | 1721 |
|
|
2014
Q4 | $191K | Buy |
19,136
+4,702
| +33% | +$40.2K | ﹤0.01% | 1761 |
|
|
2014
Q3 | $123K | Buy |
14,434
+630
| +5% | +$5.54K | ﹤0.01% | 1676 |
|
|
2014
Q2 | $122K | Buy |
13,804
+1,784
| +15% | +$15.6K | ﹤0.01% | 1675 |
|
|
2014
Q1 | $112K | Buy |
+12,020
| New | +$105K | ﹤0.01% | 1950 |
|
|
2013
Q4 | – | Sell |
-11,701
| Closed | -$118K | – | 1908 |
|
|
2013
Q3 | $103K | Hold |
11,701
| – | – | ﹤0.01% | 1729 |
|
|
2013
Q2 | $83K | Buy |
+11,701
| New | +$80.8K | ﹤0.01% | 1606 |
|
Other funds holding OPK
OIM
Aperio Group's OPK Position: Q4 2020 in Review
Aperio Group reduced its Opko Health (OPK) stake by 4.1% in Q4 2020, selling an estimated $18K and leaving 100,821 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #2066.
Aperio Group first reported a position in OPK in Q2 2013 and has held it in 30 quarters since. The position peaked at $655K in Q1 2016. 239 funds tracked by Wall St. Rank hold OPK as of Q4 2020.
- Aperio Group held 100,821 shares of Opko Health worth $398K as of Q4 2020.
- Aperio Group sold 4,319 Opko Health shares in Q4 2020, an estimated $18K.
- Opko Health made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2066 holding.
- Aperio Group first reported a position in Opko Health in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Opko Health position peaked at $655K in Q1 2016.
- 239 funds tracked by Wall St. Rank held Opko Health as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.